NOXA1 Protein

NOXA1 Protein

title: NOXA1 Protein
description: NADPH oxidase activator 1, p67phox homolog, NOX1 activator, FAD-binding regulatory subunit
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2">NOXA1 Protein</th></tr>
<tr><td><strong>Symbol</strong></td><td>NOXA1</td></tr>
<tr><td><strong>Full Name</strong></td><td>NADPH Oxidase Activator 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[NOXA1](/genes/noxa1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q86UR1](https://www.uniprot.org/uniprotkb/Q86UR1)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>51.8 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>478 amino acids</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytoplasm, plasma membrane (with NOX1 complex)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Colorectal cancer, Neuroinflammation, Inflammatory diseases</td></tr>
</table>
</div>

Overview

--- is a protein encoded by the [NOXA1](/genes/noxa1) gene that ### NOX1 Complex Activation. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.

Structure

NOXA1 (p51nox) is the activator subunit for the NOX1 NADPH oxidase complex:

Domain Architecture

• N-terminal TPR domains: Tetratricopeptide repeat domains for protein binding
• Activation domain: Binds NOX1 and activates electron transfer
• PB1 domain (C-terminal): Mediates interaction with NOXO1
• Proline-rich regions: SH3-binding motifs

...

NOXA1 Protein

title: NOXA1 Protein
description: NADPH oxidase activator 1, p67phox homolog, NOX1 activator, FAD-binding regulatory subunit
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2">NOXA1 Protein</th></tr>
<tr><td><strong>Symbol</strong></td><td>NOXA1</td></tr>
<tr><td><strong>Full Name</strong></td><td>NADPH Oxidase Activator 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[NOXA1](/genes/noxa1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q86UR1](https://www.uniprot.org/uniprotkb/Q86UR1)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>51.8 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>478 amino acids</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Cytoplasm, plasma membrane (with NOX1 complex)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Colorectal cancer, Neuroinflammation, Inflammatory diseases</td></tr>
</table>
</div>

Overview

--- is a protein encoded by the [NOXA1](/genes/noxa1) gene that ### NOX1 Complex Activation. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.

Structure

NOXA1 (p51nox) is the activator subunit for the NOX1 NADPH oxidase complex:

Domain Architecture

• N-terminal TPR domains: Tetratricopeptide repeat domains for protein binding
• Activation domain: Binds NOX1 and activates electron transfer
• PB1 domain (C-terminal): Mediates interaction with NOXO1
• Proline-rich regions: SH3-binding motifs

Comparison to p67phox

NOXA1 is the homolog of p67phox but differs in regulation:

• Constitutively active (no phosphorylation required)
• Lower affinity for Rac GTPase
• Tissue-specific expression pattern

Rac GTPase Interaction

• Binds activated Rac (Rac-GTP) through TPR domains
• Weaker interaction compared to p67phox-Rac
• Contributes to full NOX1 activation

Normal Function

NOX1 Complex Activation

NOXA1 is essential for NOX1 enzymatic activity:

FAD binding regulation: Controls FAD reduction in NOX1

Electron transfer: Activates electron flow from NADPH to oxygen

Complex assembly: PB1 domain binds NOXO1 for membrane recruitment

Rac signaling: Integrates Rac-GTP signal for activation

Superoxide Production

• Activates NOX1 to produce superoxide (O2•−)
• Important for epithelial antimicrobial defense
• Contributes to redox signaling in various tissues

Tissue Distribution

• High expression in colon epithelium
• Present in vascular smooth muscle cells
• Lower expression in brain (primarily in specific cell types)

Role in Neurodegeneration

Oxidative Stress in Brain

NOXA1/NOX1 contributes to neurodegenerative processes:

Microglial [ROS](/entities/reactive-oxygen-species): NOX1 complex activation in [microglia](/cell-types/microglia-neuroinflammation)

Neuronal damage: Superoxide and derived ROS damage [neurons](/entities/neurons)

Vascular dysfunction: NOX1 in cerebral vessels affects blood flow

Inflammatory cascade: ROS amplifies neuroinflammatory signaling

Alzheimer's Disease

• [Aβ](/proteins/amyloid-beta)-NOX1 axis: Aβ peptides may activate NOX1 complex
• Oxidative damage marker: 8-OHdG and lipid peroxidation products
• Vascular contribution: Cerebral vessel NOX1 affects CBF
• Therapeutic target: NOX1 inhibition may reduce AD oxidative stress

Parkinson's Disease

• Dopaminergic neuron vulnerability: ROS particularly toxic to DA neurons
• [α-synuclein](/proteins/alpha-synuclein) oxidation: ROS contributes to protein aggregation
• Microglial activation: NOX1 in activated microglia near Lewy bodies

Stroke and Vascular Dementia

• Ischemia-reperfusion injury: NOX1 activation during reperfusion
• [BBB](/entities/blood-brain-barrier) disruption: ROS damages tight junctions
• Inflammatory amplification: ROS activates inflammatory cascades

Molecular Mechanisms

NOX1 Complex Components

| Component | Role | Binding Partner |
|-----------|------|-----------------|
| NOX1 | Catalytic core | Membrane-bound |
| p22phox | Stabilizer | Binds NOX1 |
| NOXO1 | Organizer | Binds NOXA1 via PB1 |
| NOXA1 | Activator | Binds NOX1 activation domain |
| Rac1/2 | GTPase | Binds NOXA1 TPR |

Activation Cascade

Rac activation: GEFs activate Rac at membrane

NOXO1 recruitment: PX domain binds phosphoinositides

NOXA1 binding: PB1-PB1 interaction with NOXO1

Rac-NOXA1: Rac-GTP binds NOXA1 TPR domains

NOX1 activation: NOXA1 activates NOX1 catalytic activity

Superoxide production: Electron transfer from NADPH to O2

Electron Transfer

• NADPH → FAD → Heme → O2 → O2•−
• NOXA1 conformational change activates FAD reduction
• Critical for sustained ROS production

Therapeutic Targeting

NOX1-Selective Inhibitors

• ML171: NOX1 inhibitor (IC50 ~0.1 μM)
• Compound optimization: Structure-based drug design ongoing
• Specificity challenges: Cross-reactivity with other NOX isoforms

NOXA1-Specific Approaches

• PB1 domain inhibitors: Disrupt NOXA1-NOXO1 interaction
• TPR domain targeting: Block Rac-NOXA1 binding
• Peptide inhibitors: Competitive binding peptides

Broader NOX Inhibition

• Apocynin: Natural pan-NOX inhibitor
• VAS2870: Small molecule inhibitor
• GKT137831: NOX1/4 inhibitor in clinical trials

Key Interactions

| Interacting Protein | Function | Disease Relevance |
|-------------------|----------|-------------------|
| NOX1 | Catalytic partner | ROS generation |
| NOXO1 | Organizer partner | Complex assembly |
| Rac1/2 | GTPase activator | Signaling integration |
| p22phox | Membrane anchor | Complex stability |

See Also

• [NOXA1 Gene](/genes/noxa1)
• [NOXO1](/proteins/noxo1)
• [NOX2/CYBB](/proteins/nox2)
• [Rac1](/proteins/rac1)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Neuroinflammation](/mechanisms/neuroinflammation)

External Links

• [UniProt: Q86UR1](https://www.uniprot.org/uniprotkb/Q86UR1)
• [NCBI Gene: 126456](https://www.ncbi.nlm.nih.gov/gene/126456)

References

[Banfi et al., NOXA1 is a NOX1 activator (2003) (2003)](https://doi.org/10.1016/j.molcel.2003.08.003)

[Takeya et al., NOXA1 structure and NOX1 activation (2003) (2003)](https://doi.org/10.1074/jbc.M210060200)

[Unknown, Bedard and Krause, NOX family NADPH oxidases (2007) (2007)](https://doi.org/10.1152/physrev.00044.2005)

[Nisimoto et al., NOXA1-NOX1 activation mechanism (2010) (2010)](https://doi.org/10.1074/jbc.M109.058029)

[Sirokmány et al., NOX1 regulation and function (2016) (2016)](https://doi.org/10.1016/j.freeradbiomed.2016.03.026)

[Cifuentes-Pagano et al., NOX inhibitors (2014) (2014)](https://doi.org/10.1152/ajpheart.00044.2014)

[Altenhöfer et al., NOX1 in disease (2015) (2015)](https://doi.org/10.1007/s00109-015-1273-7)

[Drummond et al., NOX targeting in disease (2022) (2022)](https://doi.org/10.1038/s41573-022-00536-0)

[Ma et al., NOX1 in brain pathology (2022) (2022)](https://doi.org/10.3389/fncel.2022.876371)

[Crestani et al., NOX enzymes in neurodegeneration (2021) (2021)](https://doi.org/10.1016/j.nbd.2021.105345)